Human Kallikrein 12 quantitates human Kallikrein 12 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Kallikrein 12.
Human Kallikrein 12 quantitates human Kallikrein 12 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Kallikrein 12.
Human Kallikrein 12 quantitates human Kallikrein 12 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Kallikrein 12.
Kallikreins are a subset of serin proteases with various physiological functions. There is growing evidence that many kallikreins are involved in carcinogenesis and that some have potential for new cancer and other disease biomarkers. This gene is one of fifteen members of the kallicrein subfamily located in a group on chromosome 19. The alternative splicing of this gene results in three transcription variants that encode different isoforms.
Sensitivity
Sensitivity of the dosage: 0.26 ng/ml.
Measurement range
Dose range: 0.26 to 60 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Kallicrein 12.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).